Legal

Introduction To Tasigna Atherosclerosis

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Tasigna (nilotinib) is one of the most popular cancer drugs which are used all around the world. Tasigna has been found to cause a rapid, severe as well as an irreversible atherosclerosis. Therefore scientists have named this link as tasigna atherosclerosis.

Atherosclerosis can be defined as a condition which can cause limb amputation, peripheral arterial disease as well as cardiovascular problems, which can ultimately lead to death.

It was in the year 2011 when Tasigna was found to have links with atherosclerosis for the first time. Despite this, the American public was not alarmed of the risks of Tasigna.

Side Effects Of Tasigna

Image Source: Google

Hundreds of thousands of people have consumed the Tasigna drug in the hope that it would improve their health condition as well as cure them. But they remained completely unaware regarding the dangers of Tasigna atherosclerosis. To know more about tasigna as well as its links with atherosclerosis, you may check out.

The manufacturing as well as marketing of Tasigna is undertaken by the billion dollar pharmaceutical corporation Novartis which is based in Switzerland.

Novartis is known to have settled a 2013 lawsuit by way of paying $390 million to the U.S. Department of Justice. Novartis was aware regarding the Tasigna atherosclerosis risk since the year 2011. Despite this, it purposefully chose to conceal the information from the American doctors as well as the patients.

Side Effects Of Tasigna

Image Source: Google

By the year 2013, Novartis publicly admitted the link between Tasigna and atherosclerosis in Canada. There it issued a Tasigna side effects warning along with the with Health Canada. Still, there was no issue of any such warning in the United States.

If you or a family member of yours have been harmed by the dangers of Tasigna atherosclerosis, then you have the right to file a Tasigna Lawsuit and receive the required compensation which you are eligible for.

Hope you find the article helpful!